Twelve Bio

Twelve Bio is a pioneering force in Biotechnology Research, dedicated to advancing the frontiers of genetic medicine. While now part of Ensoma, Twelve Bio’s legacy of innovation continues to drive progress towards groundbreaking therapies. Their work focuses on leveraging cutting-edge gene editing technologies to develop in vivo treatments that precisely target and engineer specific cells, aiming to cure diseases from within. The primary address for Twelve Bio is Copenhagen, Zealand 2200, DK.

With a commitment to excellence and a vision for a healthier future, Twelve Bio remains at the forefront of biotechnology innovation. Their contributions to the field are significant, and their ongoing work promises to deliver transformative solutions for patients worldwide. Twelve Bio's dedication to research and development makes them a valuable contributor to the scientific community.

Twelve Bio is committed to pushing the boundaries of what's possible in biotechnology. Their focus remains on developing innovative therapies and improving patient outcomes. We invite the management team at Twelve Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight your contributions.